Translational feasibility of soluble nanobiotherapeutics with enhanced red blood cell functions-Reference-Cited by-同舟云学术

Translational feasibility of soluble nanobiotherapeutics with enhanced red blood cell functions

Published:2017-02-24 Issue:4 Volume:45 Page:671-676
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Chang Thomas Ming Swi¹

Affiliation:

1. Artificial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, Quebec, Canada

Funder

Canadian Institutes of Health Research

Canada Blood Service/Canadian Institutes of Health Research

Canada Blood Service/Canadian Institutes of Health Research Partnership Operating Grant

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2017.1293676

Reference18 articles.

1. Semipermeable Microcapsules

2. Stablisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde

3. Therapeutic applications of polymeric artificial cells

4. Artificial Cells: The Beginning of Nanomedicine

5. Artificial Cells

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tracking Research on Hemoglobin-Based Oxygen Carriers: A Scientometric Analysis and In-Depth Review;Drug Design, Development and Therapy;2023-08

2. The role of artificial cells in the fight against COVID-19: deliver vaccine, hemoperfusion removes toxic cytokines, nanobiotherapeutics lower free radicals and pCO₂ and replenish blood supply;Artificial Cells, Nanomedicine, and Biotechnology;2022-10-03

3. Soluble Nanobiotherapeutics with Enhancements of All Three Major Red Blood Cell Functions;Blood Substitutes and Oxygen Biotherapeutics;2022

4. A Brief History of the Development of Nanobiotechnology-Based Blood Substitutes;Blood Substitutes and Oxygen Biotherapeutics;2022

5. ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology;Artificial Cells, Nanomedicine, and Biotechnology;2019-04-04